Cargando…

An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice

Hepatitis B virus (HBV) is the leading cause of liver disease and hepatic carcinoma (HCC). Approximately 350 million people worldwide are infected with HBV and at risk of chronicity. An efficient HBV-tolerant murine model that mimics HBV infection in humans is desirable for HBV-related research. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Lunzhi, Wang, Tengyun, Zhang, Yali, Liu, Xuan, Zhang, Tianying, Li, Xiaoling, Liu, Pingguo, Wu, Kun, Shih, James Wai Kuo, Yuan, Quan, Cheng, Tong, Xia, Ningshao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Association for Laboratory Animal Science 2016
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111840/ https://www.ncbi.nlm.nih.gov/pubmed/27264142 http://dx.doi.org/10.1538/expanim.16-0013

Ejemplares similares

Detection and analysis of tupaia hepatocytes via mAbs against tupaia serum albumin
por: Liu, Xuan, et al.
Publicado: (2015)

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
por: Yuan, Lunzhi, et al.
Publicado: (2019)

Detection of HBV Covalently Closed Circular DNA
por: Li, Xiaoling, et al.
Publicado: (2017)

Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice
por: Yuan, Lunzhi, et al.
Publicado: (2019)

A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection
por: Yuan, Lunzhi, et al.
Publicado: (2018)

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection
por: Yuan, Lunzhi, et al.
Publicado: (2018)

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice
por: Qi, Ruoyao, et al.
Publicado: (2023)

Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus
por: Liu, Xuan, et al.
Publicado: (2023)

A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model
por: Ma, Jian, et al.
Publicado: (2023)

Animal models for emerging coronavirus: progress and new insights
por: Yuan, Lunzhi, et al.
Publicado: (2020)

A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys
por: Kang, Ciming, et al.
Publicado: (2017)

Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model
por: Yuan, Lunzhi, et al.
Publicado: (2022)

Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters
por: Yuan, Lunzhi, et al.
Publicado: (2022)

SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications
por: Yuan, Lunzhi, et al.
Publicado: (2021)

Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster
por: Yuan, Lunzhi, et al.
Publicado: (2021)

Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters
por: Yuan, Lunzhi, et al.
Publicado: (2022)

ER stress regulating protein phosphatase 2A-B56γ, targeted by hepatitis B virus X protein, induces cell cycle arrest and apoptosis of hepatocytes
por: He, Chengyong, et al.
Publicado: (2018)

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
por: Wang, Siling, et al.
Publicado: (2022)

Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model
por: Yuan, Lunzhi, et al.
Publicado: (2022)

Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection
por: Cao, Jiali, et al.
Publicado: (2019)

Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19
por: Yuan, Lunzhi, et al.
Publicado: (2021)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71
por: Xu, Longfa, et al.
Publicado: (2015)

General and Abdominal Adiposity and Risk of Death in HBV Versus Non-HBV Carriers: A 10-Year Population-based Cohort Study
por: Lin, Wen-Yuan, et al.
Publicado: (2016)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

A review of the safety and efficacy of current COVID-19 vaccines
por: Huang, Zehong, et al.
Publicado: (2022)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
por: Luo, Yong, et al.
Publicado: (2020)

A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals
por: Nicolini, Laura Ambra, et al.
Publicado: (2019)

A SCID mouse-human lung xenograft model of SARS-CoV-2 infection
por: Fu, Wenkun, et al.
Publicado: (2021)

CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
por: Zhao, Huajun, et al.
Publicado: (2022)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants
por: Zhang, Yali, et al.
Publicado: (2022)

Increased Serum Levels of sCD206 Are Associated with Adverse Prognosis in Patients with HBV-Related Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2022)

Serum Lactate Level Predicts Short-Term and Long-Term Mortality of HBV-ACLF Patients: A Prospective Study
por: Nie, Yuan, et al.
Publicado: (2020)

HBV-Specific CD8+ T-Cell Tolerance in the Liver
por: Baudi, Ian, et al.
Publicado: (2021)

Butyrate Protects against SARS-CoV-2-Induced Tissue Damage in Golden Hamsters
por: Yu, Huan, et al.
Publicado: (2023)

Monocytic MDSCs homing to thymus contribute to age-related CD8(+) T cell tolerance of HBV
por: Fang, Zhong, et al.
Publicado: (2022)

New universal primers for genotyping and resistance detection of low HBV DNA levels
por: Tong, Yongqing, et al.
Publicado: (2016)

Anti‐HBc‐nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults
por: Deng, Xuelian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qoc4q1c7534k5f5p5gedbfmujq